# q02 rev 1 - raw independent returns

tested_sha256: 28dff1aab9cdd44fea590634d5e719c03eb0813a49588133844e03d775304beb
Date: 2026-10-05. Runtime: Claude Code (VS Code), fresh Agent-tool subagents (Opus 5.5), each given
only the workspace root, its own packet path and the frozen question (closed-book: question only).
Returns below are the agents' final reports as delivered, unedited.

## Closed-book (closed-book-solver, question text only)

answer: Q1 2025 only, as far as I can recall. Adjusted diluted EPS was $1.09, the top of the projected $1.05–$1.09 range. I'm not sure about Q1 2026 or Q2 2026.

confidence: low

basis: From memory, the 2025 quarters were:
- Q1 2025: $1.09 vs. a $1.05–$1.09 range (at the top)
- Q2 2025: $1.26 vs. $1.23–$1.27
- Q3 2025: $1.30 vs. $1.28–$1.32
- Q4 2025: $1.50 vs. about $1.47–$1.53

I recall full-year 2025 at $5.15. For 2026, I may recall Q1 2026 guidance of about $1.12–$1.18, but not the actual result. Q2 2026 was reported in July 2026, after my knowledge cutoff, so I don't know it. If the question means results reported during the period, Q4 2024 ($1.34 vs. $1.31–$1.35) also missed the top.

contaminated: no. Only an automatic user-email system note was present, and it has no bearing on the question.

## Solver B (blind-solver, packet solver-2)

**answer:** Q1 2025 and Q2 2026

**confidence:** high

**path:**
1. **Q1 2025: at the top.** The range was given on Jan 22, 2025 (D01 line 319): "first-quarter 2025 adjusted diluted earnings per share of $1.05 to $1.09." The result was "adjusted diluted EPS of $1.09" (D02 lines 17/25; table line 269 shows "$1.09 $0.98"). D08 line 277 repeats the 1Q25 figure as $1.09. $1.09 equals the top.
2. **Q2 2025: not at the top.** The range was "$1.23 to $1.27" (D02 line 201). The result was "adjusted diluted EPS of $1.26" (D03 lines 17/25/369).
3. **Q3 2025: not at the top.** The range was "$1.28 to $1.32" (D03 line 299). The result was "$1.30" (D04 lines 17/25/355). As a check, the 9M figure of $3.65 (D04 line 391) minus the 1H figure of $2.35 (D03 line 411) also gives $1.30.
4. **Q4 2025: no quarterly range was projected.** D04's guidance section (lines 285–289) only "narrows the range to $5.12 to $5.18" for the full year. The result was "adjusted diluted EPS of $1.50" (D07 lines 17/23/357). The implied Q4 range is $5.12 − $3.65 = $1.47 to $5.18 − $3.65 = $1.53. $1.50 is the midpoint, so this quarter is excluded either way.
5. **Q1 2026: not at the top.** The range was "first-quarter 2026 adjusted diluted earnings per share of $1.12 to $1.18" (D07 line 283). The result was "adjusted diluted EPS of $1.15" (D08 lines 17/25/277).
6. **Q2 2026: at the top.** The range was "Abbott projects second-quarter 2026 adjusted diluted earnings per share of $1.25 to $1.31" (D08 line 205). The result was "adjusted diluted EPS of $1.31" (D10 lines 17/25; table line 365 shows "$1.31 $1.26"). $1.31 equals the top.
7. **No ranges were revised.** None of the packet documents changes a quarterly range after it was issued. D09 (Apr 17, 2026) is a derivative-settlement court notice, D11 (Aug 20, 2026) is a preterm-formula litigation release, D05 is the Exact Sciences deal release and D06 is the amended by-laws. None contains EPS guidance.
8. The decisive EPS lines in text/ match the original docs/ sources.

**minimal_documents:** D01, D02, D03, D04, D07, D08, D10.
- The two "yes" cases alone need D01 + D02 + D08 + D10. D08 could replace D02 for the Q1 2025 actual ($1.09 comparative).
- Ruling out the other quarters needs D02 (the only source of the Q2 2025 range), D03, D04 and D07.
- D10's comparative column could replace D03 for the Q2 2025 actual, but D03 is still needed for the Q3 2025 range.

**readings:**
- **Implied Q4 2025 range counted:** $1.47–$1.53 against an actual of $1.50 is the midpoint, so the answer is unchanged.
- **"At or above the top":** no quarter exceeded its top, so the answer is unchanged.
- **"Most recent projection for the quarter":** no quarterly range was updated after issue, so the answer is unchanged.

**gaps:**
- The extraction elides some sales-table rows ("[... N characters not shown on the page ...]"), but no decisive EPS or guidance line is affected.
- No Dnn.layout.txt files or PDFs exist in this packet; the sources are .txt files.
- D06 (by-laws, about 115k characters) was read only for its first 60 lines, plus a whole-file search for EPS, guidance and quarter terms that found nothing.
- D05 was read for its first 70 lines plus a whole-file search.
- D09 and D11 were read in full. D01 was read in part (lines 1–50 and 305–334) plus searches.

**contaminated:** no

Packet files used: `D:\Dev\Docket\tasks\aq-00745\runs\q02-r1-v2-28dff1aab9cdd44fea590634d5e719c03eb0813a49588133844e03d775304beb\solver-2\text\D01.txt` through `D11.txt`, and `...\solver-2\docs\abt_ex991_*.txt` for the cross-check.

## Solver A (blind-solver, packet solver-1)

**answer:** Q1 2025 and Q2 2026. In both quarters, Abbott's adjusted diluted EPS matched the top of its quarterly range exactly: $1.09 against a $1.05–$1.09 range, and $1.31 against a $1.25–$1.31 range.

**confidence:** high

**path:**
1. **Q1 2025**
   - Range: D01 (Jan 22, 2025), guidance section: "first-quarter 2025 adjusted diluted earnings per share of $1.05 to $1.09."
   - Actual: D02, earnings statement: "Diluted Earnings per Common Share, excluding Specified Items … $1.09". The headline also says "adjusted diluted EPS of $1.09". D08's prior-year column repeats $1.09.
   - $1.09 equals the top of the range. **Match.**
2. **Q2 2025**
   - Range: D02 says "second-quarter 2025 adjusted diluted earnings per share of $1.23 to $1.27."
   - Actual: D03 reports "adjusted diluted EPS of $1.26", repeated in D10's prior-year column.
   - $1.26 is one cent below the $1.27 top. No match.
3. **Q3 2025**
   - Range: D03 says "third-quarter 2025 adjusted diluted earnings per share of $1.28 to $1.32."
   - Actual: D04 reports "adjusted diluted EPS of $1.30".
   - $1.30 is the midpoint. No match.
4. **Q4 2025**
   - No quarterly range exists anywhere in the packet. D04 only "narrows the range to $5.12 to $5.18" for the full year.
   - Actual: D07 reports "adjusted diluted EPS of $1.50".
   - Implied range check: the 9M25 adjusted EPS in D04 is $3.65, so the implied Q4 range is $5.12 − $3.65 = $1.47 to $5.18 − $3.65 = $1.53. $1.50 is the midpoint. No match.
   - Cross-check: 1.09 + 1.26 + 1.30 + 1.50 = $5.15, which equals D07's full-year figure ("adjusted diluted EPS of $5.15").
5. **Q1 2026**
   - Range: D07 says "first-quarter 2026 adjusted diluted earnings per share of $1.12 to $1.18."
   - Actual: D08 reports "adjusted diluted EPS of $1.15".
   - $1.15 is the midpoint. No match.
6. **Q2 2026**
   - Range: D08 (Apr 16, 2026) says "Abbott projects second-quarter 2026 adjusted diluted earnings per share of $1.25 to $1.31."
   - Actual: D10 (Jul 16, 2026) earnings statement shows "$1.31 $1.26". The headline says "adjusted diluted EPS of $1.31".
   - Cross-check: 1H26 is $2.46, and 1.15 + 1.31 = 2.46.
   - $1.31 equals the top. **Match.**
7. **Searches for other quarterly ranges.** Phrases like "[first|second|third|fourth]-quarter 20xx adjusted diluted" appear only in D01, D02, D03, D07, D08 and D10. The D10 hit is the Q3 2026 range ($1.38–$1.46), which falls outside the window. There is no explicit Q4 2025 range and no revised range for any quarter in the window.

**minimal_documents:**
- Needed to prove the two matches: D01, D02, D08, D10.
- Needed to rule out the other four quarters as well: D03, D04, D07.
- Substitutions:
  - D08 can replace D02 for the Q1 2025 actual, but D02 is still needed for the Q2 2025 range.
  - D10 can replace D03 for the Q2 2025 actual, but D03 is still needed for the Q3 2025 range.
  - The Q3 2025 actual can be derived from D03 and D07 ($5.15 − $2.35 − $1.50 = $1.30). D04 is still needed to show that no explicit Q4 range was issued.
- Not relevant:
  - D05: Exact Sciences deal announcement
  - D06: amended by-laws
  - D09: derivative-suit settlement notice
  - D11: preterm formula litigation agreements

**readings:**
- **Implied Q4 2025 range.** If the range implied by the narrowed full-year guidance counts as a "projected" Q4 range, Q4 2025 still lands at the midpoint ($1.50 against $1.47–$1.53). The answer is unchanged.
- **Quarters reported, rather than quarters ending, in the window.** This reading covers results announced between January 2025 and June 2026. It adds Q4 2024 and drops Q2 2026, which was reported on July 16, 2026. The answer would then be Q1 2025, with Q4 2024 not determinable, because its quarterly range is not in the packet. D01 says only that full-year 2024 hit the "upper end" of guidance. I consider this the weaker reading.

**gaps:**
- There are no PDFs or `.layout.txt` files; all sources are `.txt`.
- Both docs/ and text/ contain "[… characters not shown on the page …]" elisions (121 across 7 files). They fall only in sales and specified-item table rows; none affects the EPS rows or guidance sentences.
- I read only the first 80 lines of D06 (by-laws). A full-text search of it found no EPS, guidance or quarter terms.
- All other documents were read in full.

**contaminated:** no

Files used, all under `D:\Dev\Docket\tasks\aq-00745\runs\q02-r1-v2-28dff1aab9cdd44fea590634d5e719c03eb0813a49588133844e03d775304beb\solver-1\`:
- `text\manifest.json`
- `text\D01.txt` to `text\D11.txt`
- the matching originals in `docs\` (e.g. `docs\abt_ex991_2025-01-22.txt`, `docs\abt_ex991_2026-04-16.txt`, `docs\abt_ex991_2026-07-16.txt`)

## Shortcut audit (shortcut-auditor, packet shortcut)

answer: Q1 2025 and Q2 2026, the only two quarters in the window where adjusted diluted EPS landed exactly on the top of the projected range.

verdict: clear

shortest_path:
Each quarter's range comes from the previous earnings release and the result from the next one:

| Quarter | Projected range (source) | Actual (source) | At top? |
|---|---|---|---|
| Q1 2025 | "$1.05 to $1.09" (D01, Jan 22, 2025) | "$1.09" (D02) | Yes |
| Q2 2025 | "$1.23 to $1.27" (D02) | "$1.26" (D03) | No, 1 cent short |
| Q3 2025 | "$1.28 to $1.32" (D03) | "$1.30" (D04) | No |
| Q4 2025 | No quarterly range given; D04 only narrows full-year guidance to "$5.12 to $5.18" | "$1.50" (D07) | No (see note) |
| Q1 2026 | "$1.12 to $1.18" (D07) | "$1.15" (D08) | No |
| Q2 2026 | "$1.25 to $1.31" (D08) | "$1.31" (D10) | Yes |

Note on Q4 2025: D04 reports nine-month adjusted EPS of $3.65 (1.09 + 1.26 + 1.30), so the implied Q4 range is $5.12 − 3.65 = $1.47 to $5.18 − 3.65 = $1.53. The $1.50 result is the midpoint, so Q4 is excluded either way.

sufficient_documents:
- To show both "yes" quarters: D01 + D02 for Q1 2025, and D08 + D10 for Q2 2026.
- To rule out the other four quarters: add D03, D04 and D07. The full minimal set is D01, D02, D03, D04, D07, D08, D10.
- Alternative sources for some actuals: D08's prior-year column gives Q1 2025 = $1.09, and D10's gives Q2 2025 = $1.26. Q3 2025 can also be worked out as D07 full year $5.15 − Q4 $1.50 = $3.65, minus D03 first half $2.35 = $1.30. D04 is still needed to confirm it gave no explicit Q4 range.
- Not needed: D05 (Exact Sciences deal announcement), D06 (amended By-Laws), D09 (derivative-suit settlement notice), D11 (preterm-formula litigation settlement).

searches:
- I read the manifest and D01–D05 and D07–D11 in full. For D06 I read the first ~220 lines; whole-file searches for EPS, per share, quarter, adjusted, net earnings, sales and dollar amounts found only By-Laws text.
- The phrase "quarter 20xx adjusted diluted earnings per share of" turns up exactly six quarterly ranges: Q1, Q2 and Q3 2025 and Q1, Q2 and Q3 2026. There is none for Q4 2025.
- I confirmed the missing Q4 range in the original file `docs\abt_ex991_2025-10-15.txt`. A control search on that file ("narrows the range") does match, so the empty result is real.
- I also checked the originals in docs/ for the two "yes" pairs (D01/D02 and D08/D10); they match the text versions.
- Searches for summary phrases ("upper end", "top end", "high end", "exceed", "achieved", "aligned with", "guidance range") turned up no statement about any in-window quarter. The only hit was D01's "upper end of the initial guidance ranges", which is about full-year 2024 and outside the window.
- No single document answers the question. Each quarter needs a guidance release joined to the next results release, and four negative pairs must be checked. That is ordinary cross-document joining, not a shortcut.
- Difficulty risk: one search pulls up all the quarterly ranges, and the actuals are in the headlines, so the task is easy. There is also a near-miss trap (Q2 2025, $1.26 against a $1.27 top) and out-of-window values to avoid (Q4 2024 at $1.34 in D01; the Q3 2026 range of $1.38 to $1.46 in D10).

readings/gaps:
- Q4 2025 has no explicit quarterly range in the packet. Treating it as "no projection" or using the implied $1.47 to $1.53 range both exclude it, so the answer doesn't change.
- An unlikely reading counts quarters by when results were reported. That would add Q4 2024 (reported Jan 2025, but its range isn't in the packet) and drop Q2 2026 (reported July 2026). The question asks about the quarters themselves, so I rejected this reading.
- The "[... characters not shown ...]" gaps in the extracted text affect only sales-growth rows and the top lines of the income statements, never the EPS or guidance lines.
- Contamination: none. I did not read question.txt, notes or anything outside this packet.

Files: shortcut\text\D01.txt, D02.txt, D03.txt, D04.txt, D07.txt, D08.txt, D10.txt; shortcut\docs\abt_ex991_2025-10-15.txt (under the run folder).
